Biogen Revenue Down as Multiple Sclerosis Sales Slide

Date:




Biogen swung to a loss as results were hurt by a double-digit decline in revenue from its core multiple sclerosis treatments.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related